SEMAX

Description

Overview

Semax is a synthetic heptapeptide developed from a functional fragment of adrenocorticotropic hormone (ACTH). Through targeted peptide engineering, Semax was designed to retain selected signalling characteristics of the parent peptide while removing the endocrine activity associated with the native hormone.

Its development represents an important example of how naturally occurring hormone fragments can be modified to create specialised research compounds with distinct biological characteristics.

Published scientific literature has investigated Semax across peptide engineering, neurobiology, neuroendocrinology, molecular neuroscience and regulatory peptide biology.

These investigations continue to contribute to scientific understanding of peptide signalling and central nervous system biology.

This product is supplied exclusively for legitimate laboratory, analytical and scientific research purposes. It is not intended for human or veterinary use.